This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Unigen Corporation. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Sung Sick Woo: Inventor in Plant-Based Atopic Dermatitis Treatments.
Introduction
Sung Sick Woo is an inventor based in Seoul, South Korea. His patent work includes plant-extract compositions intended to help treat and prevent atopic dermatitis. He is associated with Unigen Corporation and holds 2 patents.
Latest Patents
Woo’s latest patent descriptions concern a composition containing plant extracts, including bamboo extract, for the treatment and prevention of atopic dermatitis. The described invention uses plant-derived ingredients and is intended to regulate immune responses by inhibiting the release of histamine and leukotrienes. The patent descriptions also identify potential applications in allergic, inflammatory, and skin diseases, with a particular focus on atopic dermatitis.
The descriptions state that clinical trials demonstrated safety and beneficial effects for treating atopic dermatitis. They present the composition as a potential option for both treatment and prevention.
Career Highlights
Woo’s patent activity reflects an emphasis on applying plant-based ingredients to health-related challenges. His work connects natural extracts with research into immune responses and skin conditions.
Collaborations
Woo is associated with Unigen Corporation. His listed collaborators include Dong Seon Kim and Eun Jung Son.
Conclusion
Sung Sick Woo’s patent work focuses on plant-extract compositions for atopic dermatitis, highlighting the potential of natural ingredients in developing treatments for skin and immune-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
